Literature DB >> 23993912

Chemical composition and cellular toxicity of ethnobotanical-based hot and cold aqueous preparations of the tiger's milk mushroom (Lignosus rhinocerotis).

Beng Fye Lau1, Noorlidah Abdullah, Norhaniza Aminudin, Hong Boon Lee.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The sclerotium of the "tiger's milk mushroom" (Lignosus rhinocerotis) is used as tonic and folk medicine for the treatment of cancer, fever, cough and asthma by the local and indigenous communities. It is traditionally prepared by either boiling or maceration-like methods; however, there is no attempt to understand how different processing methods might affect their efficacies as anticancer agents. AIM OF THE STUDY: This investigation was undertaken to evaluate the cytotoxicity of the hot and cold aqueous extracts of Lignosus rhinocerotis and to deduce the nature of the chemical component(s) that might be responsible for differential cellular toxicity of the extracts.
MATERIALS AND METHODS: The hot (LR-HA) and cold (LR-CA) aqueous extracts of the sclerotium of Lignosus rhinocerotis were prepared. The levels of bioactive components in the extracts were determined and chemical profiling was performed using UPLC-ESI-MS, SDS-PAGE and SELDI-TOF MS. Cytotoxicity of LR-HA and LR-CA against a panel of human cancer and normal cell lines was assessed by the MTT and trypan blue exclusion assays. Changes in cell morphology upon treatment with the extracts were observed. The chemical composition and bioactivities data were correlated to explain the nature of the cytotoxic component(s).
RESULTS: LR-HA and LR-CA were particularly abundant in polar components. Both extracts exhibited varying degree of cytotoxicity against the cancer cell lines with LR-CA showed significantly stronger cytotoxicity (IC50: 37-355 µg/ml) than LR-HA (IC50>500 µg/ml); however, LR-CA lacked selectivity in that it also has cytotoxic effect on the normal cell lines. Based on the results of protein profiling of heat-treated LR-CA (40-100°C) coupled to the MTT assay, the cytotoxic component(s) in LR-CA were deduced to be thermo-labile, water-soluble protein/peptide(s).
CONCLUSION: Our findings have shown that the use of different preparation methods (hot and cold aqueous extraction) for Lignosus rhinocerotis has resulted in extracts with distinctively different cellular toxicity in which the cytotoxic constituents were present only in LR-CA.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemical profiling; Cytotoxic; Lignosus rhinocerus; Medicinal mushrooms; Sclerotium

Mesh:

Substances:

Year:  2013        PMID: 23993912     DOI: 10.1016/j.jep.2013.08.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies.

Authors:  Chanin Sillapachaiyaporn; Siriporn Chuchawankul
Journal:  J Tradit Complement Med       Date:  2019-08-01

2.  Proteins from Lignosus tigris with selective apoptotic cytotoxicity towards MCF7 cell line and suppresses MCF7-xenograft tumor growth.

Authors:  Boon Hong Kong; Kean Hooi Teoh; Nget Hong Tan; Chon Seng Tan; Szu Ting Ng; Shin Yee Fung
Journal:  PeerJ       Date:  2020-08-04       Impact factor: 2.984

3.  Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies.

Authors:  Sook-Shien Lee; Nget-Hong Tan; Jayalakshmi Pailoor; Shin-Yee Fung
Journal:  Front Pharmacol       Date:  2017-09-01       Impact factor: 5.810

4.  IN VITRO EFFICACY OF EXTRACTS FROM PLANTS USED BY SMALL-HOLDER FARMERS IN THE TREATMENT OF DERMATOPHILOSIS IN CATTLE.

Authors:  Daud N Ndhlovu; Patrick J Masika
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

5.  Molecular attributes and apoptosis-inducing activities of a putative serine protease isolated from Tiger Milk mushroom (Lignosus rhinocerus) sclerotium against breast cancer cells in vitro.

Authors:  Hui Yeng Y Yap; Nget Hong Tan; Szu Ting Ng; Chon Seng Tan; Shin Yee Fung
Journal:  PeerJ       Date:  2018-06-05       Impact factor: 2.984

6.  Immunomodulatory Effect and an Intervention of TNF Signalling Leading to Apoptotic and Cell Cycle Arrest on ORL-204 Oral Cancer Cells by Tiger Milk Mushroom, Lignosus rhinocerus.

Authors:  Hui Yeng Yeannie Yap; Boon Hong Kong; Chee Sum Alvin Yap; Kien Chai Ong; Rosnah Binti Zain; Soon Hao Tan; Zuraiza Mohamad Zaini; Szu Ting Ng; Chon Seng Tan; Shin Yee Fung
Journal:  Food Technol Biotechnol       Date:  2022-03       Impact factor: 3.918

7.  Transcriptome Analysis Revealed Highly Expressed Genes Encoding Secondary Metabolite Pathways and Small Cysteine-Rich Proteins in the Sclerotium of Lignosus rhinocerotis.

Authors:  Hui-Yeng Y Yap; Yit-Heng Chooi; Shin-Yee Fung; Szu-Ting Ng; Chon-Seng Tan; Nget-Hong Tan
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

8.  Lignosus rhinocerotis (Cooke) Ryvarden mimics the neuritogenic activity of nerve growth factor via MEK/ERK1/2 signaling pathway in PC-12 cells.

Authors:  Syntyche Ling-Sing Seow; Lee-Fang Eik; Murali Naidu; Pamela David; Kah-Hui Wong; Vikineswary Sabaratnam
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

9.  The potential of mycelium and culture broth of Lignosus rhinocerotis as substitutes for the naturally occurring sclerotium with regard to antioxidant capacity, cytotoxic effect, and low-molecular-weight chemical constituents.

Authors:  Beng Fye Lau; Noorlidah Abdullah; Norhaniza Aminudin; Hong Boon Lee; Ken Choy Yap; Vikineswary Sabaratnam
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

Review 10.  A Status Review of the Bioactive Activities of Tiger Milk Mushroom Lignosus rhinocerotis (Cooke) Ryvarden.

Authors:  Neeranjini Nallathamby; Chia-Wei Phan; Syntyche Ling-Sing Seow; Asweni Baskaran; Hariprasath Lakshmanan; Sri N Abd Malek; Vikineswary Sabaratnam
Journal:  Front Pharmacol       Date:  2018-01-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.